AGP Picks
View all

Middle East News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.

Press releases published on June 22, 2026

AI-supported, locally driven screening strategies enable earlier cancer detection and targeted therapy
700,000 مبيعة عالمية: كيف حظيت سيارات الدفع الرباعي  ذات التصميم الصندوقي من جيتور بتقدير عالمي؟
New Crypto Pepeto Binance Listing Update Follow Shiba Inu Success While Cardano Price Prediction Point To $9
جيتور T2 تتجاوز مبيعاتها 500,000 سيارة عالمياً في 33 شهراً متصدّرةً قطاع SUV الصندوقية عالمياً
تجسيداً لفلسفة «السفر + الرياضة»، جيتور تدعم تطوير كرة القدم العالمية
Wellbees Raises $3.6M Series A Led by Qatar Development Bank to Accelerate Gulf Expansion
KwiqEV Launches the Most Cost-Effective Charging-as-a-Service Model for Fleets — Powered by Parent Company Charge Rigs
Checkmarx Named a Leader in the 2026 Gartner Magic Quadrant for Software Supply Chain Security
Crypto News: Pepeto Presale Stage Closes in Hours While Ex-Goldman Analyst Sets XRP Price Prediction at $1,000
Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Progress Toward Production at Globex’s Bell Mountain Nevada Royalty Property
Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis
Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.